Drugs / MTR105
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00482287 | Jan → Jun 2008 | hypotensive disorder | Meditor Pharmaceuticals Ltd. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTR105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00482287 ↗ |
| Route | Intravenous | “Intravenous administration” NCT00482287 ↗ |